Ajax Health and KKR Form New Heart Failure Treatment Platform with Boston Scientific Technology

Ajax Health, backed by KKR, has announced the formation of a new entity called FlowMod25.

FlowMod is a collaboration between Boston Scientific, Ajax Health, and KKR, utilizing intellectual property developed by Boston Scientific25.

The new platform aims to accelerate the development, clinical validation, and regulatory approval of a system for treating heart failure25.

Heart failure affects the pumping action of heart muscles and currently impacts 64 million people worldwide25.

FlowMod will be led by CEO Dr. Philippe Marco, former President and COO of Epix Therapeutics and CV Ingenuity5.

KKR is investing in FlowMod through its Health Care Strategic Growth Fund II, a $4.0 billion fund focused on high-growth healthcare companies5.

The collaboration builds on a previous successful transaction (Cortex) between Ajax Health and Boston Scientific3.

This initiative represents a strategic expansion into the cardiovascular medical device space, targeting a significant market opportunity in heart failure treatment3.

The partnership leverages Boston Scientific's intellectual property, Ajax Health's device development expertise, and KKR's capital resources3.

The formation of FlowMod follows a trend of KKR partnering with established healthcare players and leveraging specialized expertise through incubator-style platforms like Ajax Health3.

Sources:

2. https://markets.businessinsider.com/news/stocks/ajax-health-and-kkr-form-new-platform-for-treating-heart-failure-1034437721

3. https://www.stocktitan.net/news/KKR/ajax-health-and-kkr-form-new-platform-to-develop-system-for-treating-7jxsahbuhs48.html

5. https://www.marketscreener.com/quote/stock/KKR-CO-INC-44486777/news/Ajax-Health-and-KKR-Form-New-Platform-to-Develop-System-for-Treating-Heart-Failure-49230625/